{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:44:10Z","timestamp":1770349450950,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1006\/pupt.2001.0284","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T21:19:16Z","timestamp":1032383956000},"page":"221-227","source":"Crossref","is-referenced-by-count":55,"title":["New Glucocorticosteroids with an Improved Therapeutic Ratio?"],"prefix":"10.1006","volume":"14","author":[{"given":"Maria G.","family":"Belvisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Wicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martyn L.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/pupt.2001.0284_RF1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin Sci"},{"key":"10.1006\/pupt.2001.0284_RF2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm.157.3.157315","article-title":"Efficacy and safety of inhaled glucocorticoids: an update","volume":"157","author":"Barnes","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1006\/pupt.2001.0284_RF3","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1096\/fasebj.6.8.1592204","article-title":"Control of transcriptional activation be steroid hormone receptors","volume":"6","author":"Gronemeyer","year":"1992","journal-title":"FASEB J"},{"key":"10.1006\/pupt.2001.0284_RF4","first-page":"459","article-title":"Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors","volume":"14","author":"Truss","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1006\/pupt.2001.0284_RF5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0092-8674(95)90201-5","article-title":"Steroid hormone receptors: many actors searching for a plot","volume":"83","author":"Beato","year":"1995","journal-title":"Cell"},{"key":"10.1006\/pupt.2001.0284_RF6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1367-5931(98)80126-9","article-title":"Therapeutic potential of selective modulators or receptor action","volume":"2","author":"Resche-Rigon","year":"1998","journal-title":"Curr Opin Chem Biol"},{"key":"10.1006\/pupt.2001.0284_RF7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/318635a0","article-title":"Primary structure and expression of a functional human glucocorticoid receptor cDNA","volume":"318","author":"Hollenberg","year":"1985","journal-title":"Nature"},{"key":"10.1006\/pupt.2001.0284_RF8","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1016\/S0021-9258(20)89627-6","article-title":"The genomic structure of the human glucocorticoid receptor","volume":"266","author":"Encio","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1006\/pupt.2001.0284_RF9","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1210\/endo.138.11.5501","article-title":"Expression and subcellular distribution of the \u03b2-isoform of the human glucocorticoid receptor","volume":"138","author":"Oakley","year":"1997","journal-title":"Endocrinology"},{"key":"10.1006\/pupt.2001.0284_RF10","doi-asserted-by":"crossref","first-page":"9550","DOI":"10.1074\/jbc.271.16.9550","article-title":"The human glucocorticoid receptor \u03b2-isoform: expression, biochemical properties and putative function","volume":"271","author":"Oakley","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1006\/pupt.2001.0284_RF11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0303-7207(99)00156-2","article-title":"Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-\u03baB: lack of effect of glucocorticoid receptor \u03b2","volume":"157","author":"Brogan","year":"1999","journal-title":"Molec Cell Endocrinol"},{"key":"10.1006\/pupt.2001.0284_RF12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.186.9.1567","article-title":"Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor \u03b2","volume":"186","author":"Leung","year":"1997","journal-title":"J Exp Med"},{"key":"10.1006\/pupt.2001.0284_RF13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(00)81177-0","article-title":"New twists in the gene regulation by glucocorticoid receptor: is DNA binding dispensable?","volume":"93","author":"Karin","year":"1998","journal-title":"Cell"},{"key":"10.1006\/pupt.2001.0284_RF14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin Sci"},{"key":"10.1006\/pupt.2001.0284_RF15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/09629359890910","article-title":"Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma","volume":"7","author":"van der Velden","year":"1998","journal-title":"Mediat Inflamm"},{"key":"10.1006\/pupt.2001.0284_RF16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s001090050242","article-title":"Transcriptional cross talk, the second mode of steroid hormone receptor action","volume":"76","author":"Gotticher","year":"1998","journal-title":"J Mol Med"},{"key":"10.1006\/pupt.2001.0284_RF17","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/j.1460-2075.1994.tb06726.x","article-title":"A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1","volume":"13","author":"Heck","year":"1994","journal-title":"EMBO J"},{"key":"10.1006\/pupt.2001.0284_RF18","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1083\/jcb.147.7.1365","article-title":"The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin","volume":"147","author":"Tuckermann","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1006\/pupt.2001.0284_RF19","doi-asserted-by":"crossref","first-page":"30081","DOI":"10.1074\/jbc.273.46.30081","article-title":"Glucocorticoid receptor transcription activity determined by spacing of receptor and non receptor DNA sites","volume":"273","author":"Pearce","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1006\/pupt.2001.0284_RF20","doi-asserted-by":"crossref","first-page":"29291","DOI":"10.1074\/jbc.273.45.29291","article-title":"Nuclear integration of glucocorticoid receptor and Nuclear Factor-kB signaling by CREB-binding protein and steroid coactivator-1","volume":"273","author":"Sheppard","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1006\/pupt.2001.0284_RF21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0091-6749(99)70325-8","article-title":"In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation","volume":"104","author":"Sousa","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1006\/pupt.2001.0284_RF22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","article-title":"The transcriptional coactivators p300 and CBP are histone acetyltransferases","volume":"87","author":"Ogryzko","year":"1996","journal-title":"Cell"},{"key":"10.1006\/pupt.2001.0284_RF23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(00)81183-6","article-title":"DNA binding of the glucocorticoid receptor is not essential for survival","volume":"93","author":"Reichardt","year":"1998","journal-title":"Cell"},{"key":"10.1006\/pupt.2001.0284_RF24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60108-8","article-title":"New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting","volume":"47","author":"Reichardt","year":"2000","journal-title":"Adv Pharmacol"},{"key":"10.1006\/pupt.2001.0284_RF25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0960-0760(99)00041-2","article-title":"Mutagenesis of the glucocorticoid receptor in mice","volume":"69","author":"Kellendonk","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1006\/pupt.2001.0284_RF26","first-page":"797","article-title":"Dissociated glucocorticoids with anti-inflammatory potential repress IL-6 gene expression by Nuclear Factor \u03ba B-dependent mechanism","volume":"56","author":"Vanden Berghe","year":"1999","journal-title":"Mol Pharm"},{"key":"10.1006\/pupt.2001.0284_RF27","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/mend.11.9.9979","article-title":"Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit anti-inflammatory activity in vivo","volume":"11","author":"Vayssi\u00e8re","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1006\/pupt.2001.0284_RF28","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.4049\/jimmunol.166.3.1975","article-title":"Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity","volume":"166","author":"Belvisi","year":"2001","journal-title":"J Immunol"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553901902846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553901902846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T02:56:57Z","timestamp":1620010617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553901902846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1094553901902846"],"URL":"https:\/\/doi.org\/10.1006\/pupt.2001.0284","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}